Genetic variation in Interleukin-32 influence the immune response against New World Leishmania species and susceptibility to American Tegumentary Leishmaniasis

Jéssica Cristina dos Santos,Valéria Bernadete Leite Quixabeira,Muriel Vilela Teodoro Silva,Michelle S. M. A. Damen,Kiki Schraa,Martin Jaeger,Marije Oosting,Samuel T. Keating,Miriam Leandro Dorta,Sebastião Alves Pinto,Fernanda Bugalho Duarte,Ledice Inácia de Araújo Pereira,Mihai G. Netea,Fátima Ribeiro-Dias,Leo A. B. Joosten
DOI: https://doi.org/10.1371/journal.pntd.0008029
2020-02-05
PLoS Neglected Tropical Diseases
Abstract:Interleukin-32 is a novel inflammatory mediator that has been described to be important in the immunopathogenesis and control of infections caused by <em>Leishmania</em> parasites. By performing experiments with primary human cells <em>in vitro</em>, we demonstrate that the expression of IL-32 isoforms is dependent on the time exposed to <em>L</em>. <em>amazonensis</em> and <em>L</em>. <em>braziliensis</em> antigens. Moreover, for the first time we show the functional consequences of three different genetic variations in the <em>IL32</em> (rs4786370, rs4349147, rs1555001) modulating IL-32γ expression, influencing innate and adaptive cytokine production after <em>Leishmania</em> exposure. Using a Brazilian cohort of 107 American Tegumentary Leishmaniasis patients and a control cohort of 245 healthy individuals, the <em>IL32</em> rs4786370 genetic variant was associated with protection against ATL, whereas the <em>IL32</em> rs4349147 was associated with susceptibility to the development of localized cutaneous and mucosal leishmaniasis. These novel insights may help improve therapeutic strategies and lead to benefits for patients suffering from <em>Leishmania</em> infections.In this study, we described how IL-32 isoforms are crucial to host defense against new world <em>Leishmania</em> species infections. Furthermore, by accessing the genotype frequency of genetic variations in <em>IL32</em> in a cohort of Brazilian patients with American Tegumentary Leishmaniasis (ATL) and controls, we have obtained indications that IL-32 is associated with disease susceptibility and the development of different clinical manifestations. Thus, this study provides us an extra evidence that the isoforms of IL-32 shape the immune response favoring the development of different cytokines produced by peripheral blood mononuclear cells that might contribute to skin/mucosal inflammation and host defense.
tropical medicine,parasitology
What problem does this paper attempt to address?